22 Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis.
http://www.nejm.org/doi/full/10.1056/NEJMoa1201964
21 Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70138-X/abstract
20 Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60734-X/fulltext
19 Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing revealed its origin and probable modes of transmission.
http://stm.sciencemag.org/content/4/148/148ra116.abstract
18 The Hendra virus attachment G glycoprotein fully protects nonhuman primates from lethal Nipah virus challenge.
http://stm.sciencemag.org/content/4/146/146ra107.abstract
17 Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70087-7/abstract
16 Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection.
http://www.nejm.org/doi/full/10.1056/NEJMoa1113244
15 The breast milk of HIV-infected mothers contains reservoirs of HIV, even when they are successfully treated with antiretroviral therapy; new approaches to prophylactic therapy are needed to prevent HIV transmission to their infants through breast-feeding.
http://stm.sciencemag.org/content/4/143/143sr3.abstract
14 Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.
http://www.pnas.org/content/109/24/9523
13 Delamanid for Multidrug-Resistant Pulmonary Tuberculosis.
http://www.nejm.org/doi/full/10.1056/NEJMoa1112433
12 Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70064-6/abstract
11 Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70033-6/abstract
10 Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(11)70368-1/abstract
9 Identification of a common immune signature in murine and human systemic Salmonellosis.
http://www.pnas.org/content/109/13/4998.abstract
7 Candida dubliniensis: An Appraisal of Its Clinical Significance as a Bloodstream Pathogen.
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0032952
6 Characterization of the Fungal Microbiota (Mycobiome) in Healthy and Dandruff-Afflicted Human Scalps.
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0032847
5 Global Distribution of Outbreaks of Water-Associated Infectious Diseases.
http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0001483
4 The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites.
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001169
3 Intermittent preventive therapy for malaria with monthly artemether—lumefantrine for the post-discharge management of severe anaemia in children aged 4—59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial.
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(11)70320-6/abstract
2 An orally available, small-molecule interferon inhibits viral replication.
http://www.nature.com/srep/2012/120210/srep00259/full/srep00259.html
|
